Keywords: integrated, biopharma, anthrax, vaccine, deal, navy, nucycle

Integrated BioPharma in anthrax vaccine deal with US Navy

Article | 27 September 2004

Print This

NuCycle Therapy, a wholly-owned subsidiary of Integrated BioPharma, has entered into an R&D agreement with the US Navy to ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in